Skip to main content
Clinical Trials/CTRI/2024/05/067675
CTRI/2024/05/067675Not yet recruitingUnknown

The value of CA 125 as a biomarker for assessing the severity of Dysmenorrheaand Menorrhagia in Adenomyosis - Nil

Dr Sutanka Sujaini0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • Females belonging to menstrual age group who understand and give informed consent
  • - Diagnosed with Adenomyosis based on USG findings using MUSA’s criteria and having symptoms of dysmenorrhea or menorrhagia
  • - Patients with above symptoms who have been given CA125 test.

Exclusion Criteria

  • - Patient who have not consented for the study.
  • - Patients diagnosed with gynecological malignancies

Investigators

Sponsor
Dr Sutanka Sujaini

Similar Trials

Unknown
Not Applicable
Analysis of predictive biomarker and analysis of correlations between toxicities and SNPs that can be related to pharmacokinetics, in ramucirumab plus paclitaxel therapy for elderly patients with unresectable or recurrent gastric cancerunresectable or recurrent gastric cancer
JPRN-UMIN000021743Tohoku Clinical Oncology Research and Education Society (T-CORE)30
Completed
Not Applicable
Analysis of predictive biomarker and analysis of correlations between toxicities and SNPs that can be related to pharmacokinetics, in trifluridine/tipiracil hydrochloride therapy for previously fluoropyrimidine-treated elderly patients with unresectable or recurrent colorectal cancerColorectal cancer
JPRN-UMIN000021742Tohoku Clinical Oncology Research and Education Society (T-CORE)20
Recruiting
Not Applicable
Biomarker analysis associated with diagnostic, recurrence, and therapeutic effects in pancreatic cancer and biliary tract cancerPancreatic cancer Biliary tract cancer
JPRN-UMIN000044430MiRTeL Co.Ltd.100
Recruiting
Not Applicable
Biomarker analysis associated with diagnostic, recurrence, and therapeutic effects in head and neck cancerHead and neck cancer
JPRN-UMIN000042276ational Cancer Center Hospital East475
Active, not recruiting
Unknown
How well certain signs in the body (biomarkers) can help doctors figure out if someone has a condition where blood flow to their abdomen is not working properly (abdominal ischemia).Early prediction and diagnosis of acute mesenteric ischemiaDigestive System
ISRCTN29102136jubljana University Medical Centre50